Enhanced ventricular function after beta-blockade in hemorrhagic shock.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001011:Aorta; D001794:Blood Pressure; D001810:Blood Volume; D004285:Dogs; D006339:Heart Rate; D006352:Heart Ventricles / Q000187:drug effects / Q000503:physiopathology*; D007545:Isoproterenol / Q000494:pharmacology*; D008297:Male; D010643:Phenoxybenzamine / Q000494:pharmacology*; D011941:Receptors, Adrenergic; D012771:Shock, Hemorrhagic / Q000503:physiopathology*; D013268:Stimulation, Chemical
D000319:Adrenergic beta-Antagonists; D011941:Receptors, Adrenergic; D010643:Phenoxybenzamine; D007545:Isoproterenol